Mark S Munro

Title: Mark S. Munro: Innovator in Nonthrombogenic Technology

Introduction

Mark S. Munro, an accomplished inventor based in Anna, Texas, has made significant contributions to the field of biomedical engineering. His innovative work focuses on reducing thrombogenicity in materials that come into contact with blood products containing albumin.

Latest Patents

Mark S. Munro holds a patent for a groundbreaking invention titled "Nonthrombogenic articles having enhanced albumin affinity." This patent describes articles that exhibit reduced thrombogenicity when interacting with blood products. The invention features a water-insoluble polymeric substrate material that has aliphatic extensions of 14 to 20 carbon units attached to its surface. When exposed to blood, these aliphatic extensions provide hydrophobic binding sites for albumin, enhancing its affinity and minimizing thrombus formation in the process.

Career Highlights

Mark is associated with the University of Texas System, where he applies his expertise to advance research in biomedical materials. His patent reflects his commitment to developing safer and more effective medical technologies that can benefit patients undergoing treatments involving blood components.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Alfred J. Quattrone and Steven R. Ellsworth. These partnerships have contributed to the innovation and success of the projects they have worked on together, reinforcing the importance of teamwork in advancing scientific research.

Conclusion

Mark S. Munro’s innovative contributions to the field of nonthrombogenic materials underscore the importance of research and development in biomedical technologies. His patent not only showcases his inventiveness but also holds the potential to enhance patient care by minimizing the risks associated with thrombus formation during medical procedures involving blood products.